Skip to main content

Ignelzi Troy A.'s Form 4 filing

Karuna Therapeutics, Inc. (KRTX) · filed Jan 19, 2023

Accession no.
0001593968-23-000170
Filed
Jan 19, 2023
Trade date
Jan 17-18, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $204.6K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Ignelzi Troy A.CIK 0001579829Officer (Chief Financial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 17, 2023Common StockMOption exerciseAcquired+817$9.20+$7,516.422,654Direct
Jan 17, 2023Common StockSSaleDisposed−817$201.41−$164,551.9721,837Direct
Jan 18, 2023Common StockMOption exerciseAcquired+200$9.20+$1,84022,037Direct
Jan 18, 2023Common StockSSaleDisposed−200$200.14−$40,02821,837Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jan 17, 2023Common StockMOption exerciseDisposed−817$0.00$0109,926Direct
Jan 18, 2023Common StockMOption exerciseDisposed−200$0.00$0109,726Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)